Sign In

Cara Weismann

Director, Program of Excellence in MPS Diseases, Orphan Disease Center, Gene Therapy Program, University of Pennsylvania

Cara M. Weismann, Ph.D., is the Director of the Program of Excellence in Mucopolysaccharidosis (MPS) Diseases at the Orphan Disease Center, part of the Gene Therapy Program at the University of Pennsylvania. Her work focuses on advancing therapies for lysosomal storage diseases, including MPS, which are rare genetic disorders caused by enzyme deficiencies. These diseases often involve multi-systemic complications, and Dr. Weismann's efforts include developing innovative treatments such as gene therapy to address central nervous system involvement in these conditions.123

Related Questions

What are Cara M. Weismann's main research interests?
How is Cara M. Weismann contributing to the treatment of MPS diseases?
What is the significance of the Orphan Disease Center at the University of Pennsylvania?
Can you provide more details about the Gene Therapy Program at the University of Pennsylvania?
What are the latest advancements in gene therapy for MPS diseases?
Cara Weismann
Cara Weismann, photo 1
Cara Weismann, photo 2
Add to my network

Location

Philadelphia, Pennsylvania